Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion type Assertion NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_head.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion description "[This provides a rationale for the therapeutic use of HSP90 inhibitors in myeloid leukemias that contain FGFR fusion proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_provenance.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion evidence source_evidence_literature NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_provenance.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion SIO_000772 21745565 NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_provenance.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion wasDerivedFrom befree-20140225 NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_provenance.
- NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_assertion wasGeneratedBy ECO_0000203 NP836158.RAVf46-4xHs-WTkH68tVx4ZsXsB4E9ql4wZXLaa5hUZIA130_provenance.